MedPath

Effect of nanocurcumin and chlorhexidine mouthwash on level of prostaglandin E2

Phase 2
Recruiting
Conditions
teeth shifting.
Encounter for other specified aftercare
Z51.8
Registration Number
IRCT20220223054108N2
Lead Sponsor
Gorgan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
88
Inclusion Criteria

Agreement to participation in the study
15 to 35 years old
Passed at least 2 mounts after fixed orthodontics treatment
Negative for hypersensitivity to Curcumin and/or chlorhexidine

Exclusion Criteria

The presence of any ulcer or intraoral infection
Severe gingival inflammation or periodontal pocket
Systemic disease
Pregnant and lactating mothers
Antibiotics usage in a month before the study
Fluoride therapy in the last 6 months
Tobacco usage
Corticosteroids and NSAIDs usage

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prostaglandin E2 before and two weeks later in all studied groups. Timepoint: Measurement of prostaglandin E2 at the study's baseline (before starting treatment) and two weeks after consuming the prescribed mouthwashes for each group. Method of measurement: Enzyme-linked Immunosorbent Assay (ELISA test).
Secondary Outcome Measures
NameTimeMethod
Patients' perception of taste in the group of patients using prescribed mouthwashes. Timepoint: The seventh day after using the prescribed mouthwashes. Method of measurement: Individually asking each of the participants about the taste of the prescribed mouthwash based on a questionnaire to check the quality of mouthwash.
© Copyright 2025. All Rights Reserved by MedPath